Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 8 studies | 25% ± 9% | |
basal cell | 5 studies | 22% ± 4% | |
squamous epithelial cell | 3 studies | 39% ± 21% | |
ciliated cell | 3 studies | 18% ± 2% | |
keratinocyte | 3 studies | 46% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 90% | 2178.63 | 1627 / 1809 | 21% | 3.73 | 97 / 472 |
esophagus | 40% | 2988.59 | 580 / 1445 | 66% | 38.90 | 120 / 183 |
tonsil | 0% | 0 | 0 / 0 | 93% | 45.12 | 42 / 45 |
pancreas | 2% | 12.04 | 7 / 328 | 63% | 7.29 | 113 / 178 |
uterus | 2% | 53.70 | 3 / 170 | 56% | 27.01 | 257 / 459 |
lung | 13% | 123.69 | 74 / 578 | 35% | 11.79 | 407 / 1155 |
ovary | 1% | 7.55 | 2 / 180 | 40% | 4.54 | 174 / 430 |
peripheral blood | 35% | 324.03 | 328 / 929 | 0% | 0 | 0 / 0 |
bladder | 5% | 18.00 | 1 / 21 | 30% | 12.31 | 149 / 504 |
stomach | 2% | 34.03 | 8 / 359 | 19% | 4.04 | 55 / 286 |
intestine | 1% | 8.49 | 13 / 966 | 19% | 4.56 | 98 / 527 |
adipose | 20% | 461.75 | 240 / 1204 | 0% | 0 | 0 / 0 |
breast | 2% | 26.86 | 9 / 459 | 12% | 1.45 | 136 / 1118 |
thymus | 0% | 0.36 | 1 / 653 | 4% | 0.24 | 22 / 605 |
brain | 0% | 0.11 | 1 / 2642 | 3% | 0.31 | 23 / 705 |
liver | 0% | 1.77 | 1 / 226 | 2% | 0.25 | 9 / 406 |
prostate | 2% | 4.79 | 4 / 245 | 1% | 0.03 | 3 / 502 |
adrenal gland | 1% | 8.97 | 3 / 258 | 1% | 0.07 | 2 / 230 |
heart | 2% | 18.83 | 14 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 10.69 | 15 / 1335 | 0% | 0 | 0 / 0 |
spleen | 1% | 3.71 | 2 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.05 | 6 / 901 |
muscle | 0% | 0.58 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0042730 | Biological process | fibrinolysis |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0001533 | Cellular component | cornified envelope |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
Gene name | SERPINB2 |
Protein name | Serpin family B member 2 Plasminogen activator inhibitor 2 (PAI-2) (Monocyte Arg-serpin) (Placental plasminogen activator inhibitor) (Serpin B2) (Urokinase inhibitor) |
Synonyms | PAI2 PLANH2 |
Description | FUNCTION: Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1. |
Accessions | ENST00000413956.5 ENST00000299502.9 ENST00000443281.1 E7EPJ9 E9PDK7 ENST00000457692.5 P05120 ENST00000404622.5 E7ERB5 |